Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders
2023 · Annals of Hematology · 18 citations
https://doi.org/10.1007/s00277-023-05287-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
1
Citations
1
h-index
0
i10-index
MIDORI SHIMA is an academic researcher. The author has contributed to research in topics: Legal and Regulatory Analysis & Linguistic, Cultural, and Literary Studies & Military Technology and Strategies. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat